EPIDEL Canadian Trademark Information

On Friday, September 21, 2012, a canadian trademark registration was filed for EPIDEL by Ripple Therapeutics Corporatio *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1595233. The current status of this trademark filing is Registration published. The EPIDEL trademark is filed in the description of Bioresponsive resorbable polymeric drug relief delivery system used to combat infection caused by implantable medical devices; bioresponsive resorbable polymers for use in the manufacture of drug delivery systems used to combat infection caused by implantable medical devices; bioresponsive resorbable polymers containing pharmaceuticals and sold as a component of medical and surgical devices and instruments used in cardiovascular, urological, neurological and musculoskeletal applications, and ophthalmic surgical implants made from living human tissue, implants made from living human tissue for repairing muscular and other human tissue, and for augmenting, strengthening, and aiding muscular and other human tissue in performing a function, surgical implants made from living tissue for orthopaedic bone, joint, and cartilage repair, connective tissue implants made from living human tissue; synthetic polymer coatings sold as an integral component of the above listed implants; drug delivery systems, namely drug eluting stents, catheters, implants and cuffs; connective tissue implants made from artificial material; stents, guide wires and catheters; prosthetic devices, namely, prosthetic ligaments, prosthetic joints, prosthetic arms, prosthetic feet, prosthetic legs, prosthetic hands, prosthetic sockets used to fasten prosthetic limbs to the body, prosthetic tissues for parietal, visceral and vascular use, prosthetic intraocular implants, prosthetic and filling materials, namely, artificial materials for use in the replacement of orthopaedic bones, cushion liners for prosthetic limbs, prosthetic instruments for dental purposes; dialysis implants made from artificial materials, cardiac pacemaker circuitry and heart valve implants made from artificial materials; synthetic polymer coatings sold as an integral component of the above listed drug delivery systems, stents, prosthetic devices and implants none of the foregoing being specifically intended for wound care or wound management , Bioresponsive resorbable polymeric drug relief delivery system used to combat infection caused by implantable medical devices; bioresponsive resorbable polymers for use in the manufacture of drug delivery systems used to combat infection caused by implantable medical devices; bioresponsive resorbable polymers containing pharmaceuticals and sold as a component of medical and surgical devices and instruments used in cardiovascular, urological, neurological and musculoskeletal applications, and ophthalmic surgical implants made from living human tissue, implants made from living human tissue for repairing muscular and other human tissue, and for augmenting, strengthening, and aiding muscular and other human tissue in performing a function, surgical implants made from living tissue for orthopaedic bone, joint, and cartilage repair, connective tissue implants made from living human tissue; synthetic polymer coatings sold as an integral component of the above listed implants; drug delivery systems, namely drug eluting stents, catheters, implants and cuffs; connective tissue implants made from artificial material; stents, guide wires and catheters; prosthetic devices, namely, prosthetic ligaments, prosthetic joints, prosthetic arms, prosthetic feet, prosthetic legs, prosthetic hands, prosthetic sockets used to fasten prosthetic limbs to the body, prosthetic tissues for parietal, visceral and vascular use, prosthetic intraocular implants, prosthetic and filling materials, namely, artificial materials for use in the replacement of orthopaedic bones, cushion liners for prosthetic limbs, prosthetic instruments for dental purposes; dialysis implants made from artificial materials, cardiac pacemaker circuitry and heart valve implants made from artificial materials; synthetic polymer coatings sold as an integral component of the above listed drug delivery systems, stents, prosthetic devices and implants none of the foregoing being specifically intended for wound care or wound management , Bioresponsive resorbable polymeric drug relief delivery system used to combat infection caused by implantable medical devices; bioresponsive resorbable polymers for use in the manufacture of drug delivery systems used to combat infection caused by implantable medical devices; bioresponsive resorbable polymers containing pharmaceuticals and sold as a component of medical and surgical devices and instruments used in cardiovascular, urological, neurological and musculoskeletal applications, and ophthalmic surgical implants made from living human tissue, implants made from living human tissue for repairing muscular and other human tissue, and for augmenting, strengthening, and aiding muscular and other human tissue in performing a function, surgical implants made from living tissue for orthopaedic bone, joint, and cartilage repair, connective tissue implants made from living human tissue; synthetic polymer coatings sold as an integral component of the above listed implants; drug delivery systems, namely drug eluting stents, catheters, implants, dressings and cuffs; connective tissue implants made from artificial material; stents, guide wires and catheters; prosthetic devices, namely, prosthetic ligaments, prosthetic joints, prosthetic arms, prosthetic feet, prosthetic legs, prosthetic hands, prosthetic sockets used to fasten prosthetic limbs to the body, prosthetic tissues for parietal, visceral and vascular use, prosthetic intraocular implants, prosthetic and filling materials, namely, artificial materials for use in the replacement of orthopaedic bones, cushion liners for prosthetic limbs, prosthetic instruments for dental purposes; dialysis implants made from artificial materials, cardiac pacemaker circuitry and heart valve implants made from artificial materials; synthetic polymer coatings sold as an integral component of the above listed drug delivery systems, stents, prosthetic devices and implants. , Bioresponsive resorbable polymeric drug relief delivery system used to combat infection caused by implantable medical devices; bioresponsive resorbable polymers for use in the manufacture of drug delivery systems used to combat infection caused by implantable medical devices; bioresponsive resorbable polymers containing pharmaceuticals and sold as a component of medical and surgical devices and instruments used in cardiovascular, urological, neurological and musculoskeletal applications, and ophthalmic surgical implants made from living human tissue, implants made from living human tissue for repairing muscular and other human tissue, and for augmenting, strengthening, and aiding muscular and other human tissue in performing a function, surgical implants made from living tissue for orthopaedic bone, joint, and cartilage repair, connective tissue implants made from living human tissue; synthetic polymer coatings sold as an integral component of the above listed implants; drug delivery systems, namely drug eluting stents, catheters, implants and cuffs; connective tissue implants made from artificial material; stents, guide wires and catheters; prosthetic devices, namely, prosthetic ligaments, prosthetic joints, prosthetic arms, prosthetic feet, prosthetic legs, prosthetic hands, prosthetic sockets used to fasten prosthetic limbs to the body, prosthetic tissues for parietal, visceral and vascular use, prosthetic intraocular implants, prosthetic and filling materials, namely, artificial materials for use in the replacement of orthopaedic bones, cushion liners for prosthetic limbs, prosthetic instruments for dental purposes; dialysis implants made from artificial materials, cardiac pacemaker circuitry and heart valve implants made from artificial materials; synthetic polymer coatings sold as an integral component of the above listed drug delivery systems, stents, prosthetic devices and implants none of the foregoing being specifically intended for wound care or wound management .